质子束治疗纵隔霍奇金淋巴瘤的前瞻性临床疗效与安全性研究
该前瞻性观察队列纳入162例纵隔霍奇金淋巴瘤患者,2013年5月至2020年12月接受笔束扫描质子束治疗,中位剂量30 GyE,中位随访59.1个月。无病生存率95.1%、总生存率98.8%、局部控制率98.8%,最常见急性毒性为1级食管黏膜炎(47%),最常见晚期毒性为2级甲状腺功能减退(23%),未观察到意外急晚期毒性。
要点
- 笔束扫描质子束治疗纵隔霍奇金淋巴瘤的局部控制率达98.8%,疗效良好。
- 急性毒性以1级食管黏膜炎(47%)和1级皮炎(40%)为主,3级及以上急性毒性未见报告。
- 最常见晚期毒性为2级甲状腺功能减退(23%),3例(1.8%)随访期间接受冠状动脉介入。
核心结论
- 笔束扫描质子束治疗纵隔霍奇金淋巴瘤在毒性和局部控制方面安全有效,即使照射纵隔靶区也未观察到意外急晚期毒性。
研究设计与样本
- 前瞻性观察队列研究,2013年5月至2020年12月共162例纵隔霍奇金淋巴瘤患者接受笔束扫描质子束治疗,中位年龄32岁(范围18.4-79.2),随访至2024年4月。
- 中位应用剂量30 GyE(范围20-40),146例患者采用深吸气屏气以增强靶向精度。
主要发现
- 无病生存率95.1%,总生存率98.8%,局部控制率98.8%,中位随访59.1个月(范围4-120.1)。
- 最常见急性毒性为食管和皮肤毒性:1级食管黏膜炎76例(47%),2级16例(10%);1级皮炎65例(40%),2级4例(3%)。
- 1级肺毒性8例(4.9%),2级1例(0.6%);最常见晚期毒性为2级甲状腺功能减退37例(23%)。
- 3例(1.8%)随访期间接受冠状动脉介入,1例放疗后3个月诊断为肝细胞癌。
临床怎么用
- 对于纵隔霍奇金淋巴瘤患者,笔束扫描质子束治疗可作为兼顾局部控制与正常组织保护的选择,尤其适用于需保护纵隔周围关键器官的情形。
- 治疗中可采用深吸气屏气技术辅助靶向精度,并关注食管黏膜炎、皮炎及甲状腺功能减退等急晚期毒性的监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proton beam therapy using pencil beam scanning is an advanced radiotherapy technique that utilises proton beams to precisely target tumours. It is known for its enhanced ability in sparing healthy tissue and potentially reducing toxicity. Clinical experience with pencil beam scanning in the treatment of mediastinal Hodgkin lymphoma remains limited. PATIENTS AND METHODS: This study aimed to evaluate the toxicity and outcomes of a prospectively observed cohort. A total of 162 patients were irradiated between May 2013 and December 2020, with a median age of 32 years (range: 18.4-79.2) and followed up until April 2024. The median applied dose was 30 GyE (range: 20-40). Deep inspiration breath hold was used in 146 patients to enhance targeting precision. RESULTS: The disease-free survival, overall survival and local control rates were 95.1 %, 98.8 % and 98.8 %, respectively. The median follow-up was 59.1 months (range: 4-120.1). The most common acute toxicities observed were oesophageal and skin toxicity. Grade 1 oesophageal mucositis occurred in 76 patients (47 %), grade 2 in 16 patients (10 %). Dermatitis of grade 1 and 2 was observed in 65 (40 %) and 4 (3 %) patients respectively. Grade 1 pulmonary toxicity presented in 8 patients (4.9 %), and grade 2 in one patient (0.6 %). The most predominant late toxicity was grade 2 hypothyroidism in 37 patients (23 %). Three patients (1.8 %) underwent coronary interventions during follow-up, and one patient was diagnosed with hepatocellular carcinoma 3 months post-RT. No unexpected acute or late toxicities were observed. CONCLUSION: Proton beam therapy using pencil beam scanning is a safe and effective technique in terms of toxicity and local control, even when irradiating mediastinal targets.
引用
- Dědečková K, Andrlik M, Móciková H, et al. Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety. Radiother Oncol. 2025. PMID: 40355029. doi:10.1016/j.radonc.2025.110931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。